237 related articles for article (PubMed ID: 21819371)
1. Heart allograft involvement by posttransplant lymphoproliferative disorders: report from the PTLD. Int survey.
Khedmat H; Taheri S
Exp Clin Transplant; 2011 Aug; 9(4):258-64. PubMed ID: 21819371
[TBL] [Abstract][Full Text] [Related]
2. CD20 antigen expression by lymphoproliferative disorders after kidney transplant is independently associated with a poor outcome: PTLD.Int survey.
Khedmat H; Taheri S
Exp Clin Transplant; 2012 Aug; 10(4):325-31. PubMed ID: 22758374
[TBL] [Abstract][Full Text] [Related]
3. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
[TBL] [Abstract][Full Text] [Related]
4. Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses.
Kasiske BL; Kukla A; Thomas D; Wood Ives J; Snyder JJ; Qiu Y; Peng Y; Dharnidharka VR; Israni AK
Am J Kidney Dis; 2011 Dec; 58(6):971-80. PubMed ID: 21930332
[TBL] [Abstract][Full Text] [Related]
5. An approach to finding indications and contraindications for nephrectomy in post-transplant renal graft lymphomas: PTLD.Int survey.
Gholipour-Shoiili A; Gholipour-Shoiili H; Taheri S
Hematol Oncol Stem Cell Ther; 2011; 4(4):167-72. PubMed ID: 22198192
[TBL] [Abstract][Full Text] [Related]
6. Small intestinal involvement by lymphoproliferative disorders post-renal transplantation: a report from the post-transplant lymphoproliferative disorder international survey.
Khedmat H; Taheri S
Saudi J Kidney Dis Transpl; 2013 May; 24(3):487-94. PubMed ID: 23640619
[TBL] [Abstract][Full Text] [Related]
7. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ; Homan van der Heide JJ; Veeger NJ; Kluin PM; Kluin-Nelemans HC
Clin Transplant; 2005 Jun; 19(3):327-34. PubMed ID: 15877793
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow involvement by lymphoproliferative disorders after renal transplantation: PTLD. Int. Survey.
Izadi M; Fazel M; Saadat SH; Taheri S
J Cancer Res Ther; 2012; 8(1):62-7. PubMed ID: 22531516
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow involvement by lymphoproliferative disorders post liver transplantation: PTLD Int Survey.
Khedmat H; Taheri S
Acta Med Indones; 2012 Jul; 44(3):207-13. PubMed ID: 22983075
[TBL] [Abstract][Full Text] [Related]
10. More benign lymphoproliferative disease after liver transplant in infants.
Khedmat H; Ghamar-Chehreh ME; Amini M; Taheri S
Prog Transplant; 2013 Jun; 23(2):158-64. PubMed ID: 23782664
[TBL] [Abstract][Full Text] [Related]
11. Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study.
OʼRegan JA; Prendeville S; McCaughan JA; Traynor C; OʼBrien FJ; Ward FL; OʼDonovan D; Kennedy C; Berzan E; Kinsella S; Williams Y; OʼKelly P; Deady S; Comber H; Leader M; Conlon PJ
Transplantation; 2017 Mar; 101(3):657-663. PubMed ID: 27214265
[TBL] [Abstract][Full Text] [Related]
12. Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization.
Lones MA; Lopez-Terrada D; Weiss LM; Shintaku IP; Said JW
Arch Pathol Lab Med; 1997 Jul; 121(7):701-6. PubMed ID: 9240905
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and prognosis of post-transplant lymphoproliferative disorders within renal allograft: Report from the PTLD.Int. Survey.
Khedmat H; Taheri S
Ann Transplant; 2010; 15(3):80-6. PubMed ID: 20877272
[TBL] [Abstract][Full Text] [Related]
14. Features, predictors and prognosis of lymphoproliferative disorders post-liver transplantation regarding disease presentation time: report from the PTLD.Int. survey.
Izadi M; Taheri S
Ann Transplant; 2011; 16(1):39-47. PubMed ID: 21436773
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus infection can affect lymphoproliferative disorders only as a cofactor for Epstein-Barr virus in liver transplant recipients: PTLD.Int survey.
Khedmat H; Taheri S
Exp Clin Transplant; 2012 Apr; 10(2):141-7. PubMed ID: 22432758
[TBL] [Abstract][Full Text] [Related]
16. Early onset post transplantation lymphoproliferative disorders: analysis of international data from 5 studies.
Khedmat H; Taheri S
Ann Transplant; 2009; 14(3):74-7. PubMed ID: 19644164
[TBL] [Abstract][Full Text] [Related]
17. Hepatic lymphomas post renal transplantation may signify worse disease behavior: analysis of data from 26 international studies.
Khedmat H; Taheri S
Arab J Nephrol Transplant; 2011 Sep; 4(3):109-16. PubMed ID: 22026333
[TBL] [Abstract][Full Text] [Related]
18. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
Tai CC; Curtis JL; Szmuszkovicz JR; Horn MV; Ford HR; Woo MS; Wang KS
J Pediatr Surg; 2008 Dec; 43(12):2174-7. PubMed ID: 19040929
[TBL] [Abstract][Full Text] [Related]
19. Posttransplant lymphoproliferative disorder with lung involvement in a renal transplant recipient.
Mirza EI; Mutluay R; Suyani E; Okyay GU; Akyurek N; Aki SZ; Derici U; Arinsoy T
Exp Clin Transplant; 2011 Dec; 9(6):425-8. PubMed ID: 22142053
[TBL] [Abstract][Full Text] [Related]
20. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation.
Cherikh WS; Kauffman HM; McBride MA; Maghirang J; Swinnen LJ; Hanto DW
Transplantation; 2003 Nov; 76(9):1289-93. PubMed ID: 14627905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
